Bextra Side Effects Attorneys
Bextra Drug Recall Litigation

Pfizer, Inc. the world's largest drug maker, introduced Bextra in the United States in 2001, two years after Vioxx hit the market. Both are COX-2 inhibitor drugs. Bextra is prescribed for the treatment of osteoarthritis, adult rheumatoid arthritis, and the pain associated with menstrual cramping.

On April 7, 2005, Bextra was pulled from the market after it was linked to an increased incidence of heart attacks and strokes as well as a potentially fatal skin allergy know as Stevens Johnson Syndrome. The removal came six months after Vioxx was withdrawn from the market because of side effects including heart attack and stroke.

In a study released in November 2004, it was found that patients who took Bextra were more than twice as likely to suffer heart attacks or stroke. The study included 5,930 patients, some taking Bextra and some given a placebo.

"This is a time bomb waiting to go off," Dr. Garret A. FitzGerald, a University of Pennsylvania cardiologist and pharmacologist, told The New York Times after presenting the study data. "The magnitude of the signal with Bextra is even higher than what we saw in Vioxx."

Merck & Co. removed Vioxx from the market Sept. 30, 2004. A deluge of lawsuits has followed by people who used the drug and claim to have suffered severe heart attacks and stroke as a result. Many of those lawsuits were filed for patients and their families by Kline & Specter.

One expert, Dr. Curt Furberg, professor of public health sciences at Wake Forest University School of Medicine, who helped conduct the Bextra study, said Bextra presents the same dangers as Vioxx. "Basically, we showed that Bextra is no different than Vioxx ," he told The Times. "And Pfizer is trying to suppress that information."

Pfizer introduced Bextra in the United States in 2001, two years after Vioxx hit the market. Both are COX-2 inhibitor drugs as is Celebrex, also made by Pfizer. On April 7, 2005, when Bextra was removed from the market, the FDA also asked Pfizer to add a "black box" warning - its strongest warning - to the Celebrex label.

For it's part, Pfizer said it disagrees with the latest FDA decision that Bextra should be withdrawn and that it will hold further discussions with the FDA on returning Bextra to the market. Pfizer in the past has denied problems with Bextra for arthritis patients, saying that the only patients who experienced heart problems were those at very high risk for heart disease.

Kline & Specter, P.C. , with more than 30 experienced attorneys (four of them also highly regarded doctors), is one of the nation's leading law firms with the ability to litigate Bextra lawsuits. Kline & Specter has the skill, experience and ability to achieve the right result for you and your family.

Kline & Specter, P.C. is a national pharmaceutical litigation law firm. We represent Bextra side effects victims throughout the United States. Click here to visit our Bextra web site. Find out about more about Kline & Specter including our Doctor/Lawyer Team and our Notable Cases.

Bextra FAQs
Bextra News

Read the Luis Flores Story

If you or a loved one has been harmed by Bextra or another a defective drug, you need a law firm with the resources and the experience to bring you justice. Please call or e-mail the Bextra heart attack and stroke attorneys at January 31, 2007free and we don't get paid unless you do. Our expertise will help you get the compensation you deserve.

Pharmaceutical Injury Lawyers

Click here to contact us.

This page was last updated on September 20, 2005.